Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
NexPoint Residential price target raised to $64 from $57 at Truist » 09:31
08/25/21
08/25
09:31
08/25/21
09:31
NXRT

NexPoint Residential

$60.78 /

+0.38 (+0.63%)

Truist analyst Michael…

Truist analyst Michael Lewis raised the firm's price target on NexPoint Residential to $64 from $57 but keeps a Hold rating on the shares. The analyst notes that pricing power has improved in the REIT's markets and he is modeling a 5.4% same-store net operating income growth for FY21, which is just above the high end of its management's guidance range of 2.7%-5.2%. Lewis adds however that he is concerned with NexPoint's valuation, which is at 29-times enterprise value to expected EBITDA multiple and is among the highest in his apartment coverage universe.

ShowHide Related Items >><<
NXRT NexPoint Residential
$60.78 /

+0.38 (+0.63%)

06/04/21 Truist
NexPoint Residential price target raised to $57 from $47 at Truist
04/06/21 Raymond James
NexPoint Residential price target raised to $53 from $49 at Raymond James
11/03/20
Fly Intel: Top five analyst downgrades
11/03/20 Raymond James
NexPoint Residential downgraded to Outperform from Strong Buy at Raymond James
NXRT NexPoint Residential
$60.78 /

+0.38 (+0.63%)

Over a month ago
Earnings
NexPoint Residential reports Q2 AFFO EPS 65c, consensus 65c » 08:06
07/27/21
07/27
08:06
07/27/21
08:06
NXRT

NexPoint Residential

$61.14 /

+1.04 (+1.73%)

Reports Q2 revenue…

Reports Q2 revenue $52.6M, consensus $53.44M. Q2 Same Store properties average effective rent, total revenue and NOI2 increased 3.6%, 3.4% and 0.6%, respectively, and occupancy increased 70 bps over the prior year period.

ShowHide Related Items >><<
NXRT NexPoint Residential
$61.14 /

+1.04 (+1.73%)

06/04/21 Truist
NexPoint Residential price target raised to $57 from $47 at Truist
04/06/21 Raymond James
NexPoint Residential price target raised to $53 from $49 at Raymond James
11/03/20
Fly Intel: Top five analyst downgrades
11/03/20 Raymond James
NexPoint Residential downgraded to Outperform from Strong Buy at Raymond James
NXRT NexPoint Residential
$61.14 /

+1.04 (+1.73%)

Over a quarter ago
Recommendations
NexPoint Residential price target raised to $57 from $47 at Truist » 08:07
06/04/21
06/04
08:07
06/04/21
08:07
NXRT

NexPoint Residential

$53.43 /

-0.165 (-0.31%)

Truist analyst Michael…

Truist analyst Michael Lewis raised the firm's price target on NexPoint Residential to $57 from $47 and keeps a Hold rating on the shares as part of a broader research note on Apartment REITs. The analyst is citing improving leasing volume and rent spreads along with a shortage of housing, fiscal stimulus, and a short lease duration outweighing inflation trends to support the group's "elevated valuations" which already trade above pre-pandemic levels.

ShowHide Related Items >><<
NXRT NexPoint Residential
$53.43 /

-0.165 (-0.31%)

04/06/21 Raymond James
NexPoint Residential price target raised to $53 from $49 at Raymond James
11/03/20
Fly Intel: Top five analyst downgrades
11/03/20 Raymond James
NexPoint Residential downgraded to Outperform from Strong Buy at Raymond James
09/15/20 Baird
NexPoint Residential assumed with an Outperform at Baird
NXRT NexPoint Residential
$53.43 /

-0.165 (-0.31%)

Earnings
NexPoint Residential reports Q1 AFFO 64c, consensus 60c » 08:09
04/27/21
04/27
08:09
04/27/21
08:09
NXRT

NexPoint Residential

$50.74 /

+0.28 (+0.55%)

Reports Q revenue $51.8M,…

Reports Q revenue $51.8M, consensus $51.95M. Q1 Same Store properties average effective rent, total revenue and occupancy increased 1.2%, 2.1% and 110 bps, respectively, and NOI decreased (0.3%) from the prior year period.

ShowHide Related Items >><<
NXRT NexPoint Residential
$50.74 /

+0.28 (+0.55%)

04/06/21 Raymond James
NexPoint Residential price target raised to $53 from $49 at Raymond James
11/03/20
Fly Intel: Top five analyst downgrades
11/03/20 Raymond James
NexPoint Residential downgraded to Outperform from Strong Buy at Raymond James
09/15/20 Baird
NexPoint Residential assumed with an Outperform at Baird
NXRT NexPoint Residential
$50.74 /

+0.28 (+0.55%)

Recommendations
NexPoint Residential price target raised to $53 from $49 at Raymond James » 07:05
04/06/21
04/06
07:05
04/06/21
07:05
NXRT

NexPoint Residential

$46.52 /

-0.1 (-0.21%)

Raymond James analyst…

Raymond James analyst Buck Horne raised the firm's price target on NexPoint Residential to $53 from $49 and keeps an Outperform rating on the shares. Although the outlook for 2021 FFO growth has been limited by expectations of significant property tax assessments this year, Horne remains highly constructive on the longer-term outlook for NexPoint's value-add strategy in high-growth Sun Belt markets, the analyst tells investors in a research note.

ShowHide Related Items >><<
NXRT NexPoint Residential
$46.52 /

-0.1 (-0.21%)

NXRT NexPoint Residential
$46.52 /

-0.1 (-0.21%)

11/03/20
Fly Intel: Top five analyst downgrades
11/03/20 Raymond James
NexPoint Residential downgraded to Outperform from Strong Buy at Raymond James
09/15/20 Baird
NexPoint Residential assumed with an Outperform at Baird
08/26/20 Truist
NexPoint Residential price target raised to $44 from $34 at Truist
NXRT NexPoint Residential
$46.52 /

-0.1 (-0.21%)

Earnings
NexPoint Residential reports Q4 core FFO 56c, consensus 58c » 07:33
02/16/21
02/16
07:33
02/16/21
07:33
NXRT

NexPoint Residential

$42.42 /

+0.15 (+0.35%)

Reports Q4 revenue…

Reports Q4 revenue $50.5M, consensus $51.17M. Q4 Same Store NOI decreased 1.8% to $24.6M, compared to $25.1M for the Q4 of FY19, which was impacted by a 21.0% increase in real estate tax accruals.

ShowHide Related Items >><<
NXRT NexPoint Residential
$42.42 /

+0.15 (+0.35%)

NXRT NexPoint Residential
$42.42 /

+0.15 (+0.35%)

11/03/20
Fly Intel: Top five analyst downgrades
11/03/20 Raymond James
NexPoint Residential downgraded to Outperform from Strong Buy at Raymond James
09/15/20 Baird
NexPoint Residential assumed with an Outperform at Baird
08/26/20 Truist
NexPoint Residential price target raised to $44 from $34 at Truist
NXRT NexPoint Residential
$42.42 /

+0.15 (+0.35%)

Downgrade
Fly Intel: Top five analyst downgrades » 09:48
11/03/20
11/03
09:48
11/03/20
09:48
PACB

Pacific Biosciences

$11.60 /

-1.67 (-12.58%)

, SEDG

SolarEdge

$204.20 /

-64.18 (-23.91%)

, HES

Hess Corp.

$38.50 /

+0.485 (+1.28%)

, IPGP

IPG Photonics

$190.57 /

+ (+0.00%)

, NXRT

NexPoint Residential

$43.32 /

-1.625 (-3.62%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Pacific Biosciences (PACB) downgraded to Neutral from Overweight at Piper Sandler with analyst Steven Mah saying he continues to believe in Pacific's "highly accurate" long-read sequencing technology and the commercial expertise that Christian Henry brings as new CEO, but he's downgrading the shares based on the lack of visibility on future COVID-19 related lab closures and the stock's valuation. 2. SolarEdge (SEDG) downgraded to Underperform from Market Perform at Northland and downgraded to Perform from Outperform at Oppenheimer. 3. Hess Corp. (HES) downgraded to Hold from Buy at Argus with analyst Bill Selesky saying he is "concerned" with the company's continued losses and rising debt to capital ratio, which rose to 56.5% from the past year's level of 37%. 4. IPG Photonics (IPGP) downgraded to Market Perform from Outperform at Raymond James with analyst Brian Gesuale saying he thinks the alpha has largely been captured at a $190 stock price and believes sustainable share price north of $210 carries material multiple compression risk, overlooks the competitive environment in China and requires significant earnings growth that would eclipse the generational earnings peak of 2018. 5. NexPoint Residential (NXRT) downgraded to Outperform from Strong Buy at Raymond James with analyst Buck Horne citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
SEDG SolarEdge
$204.20 /

-64.18 (-23.91%)

PACB Pacific Biosciences
$11.60 /

-1.67 (-12.58%)

NXRT NexPoint Residential
$43.32 /

-1.625 (-3.62%)

IPGP IPG Photonics
$190.57 /

+ (+0.00%)

HES Hess Corp.
$38.50 /

+0.485 (+1.28%)

PACB Pacific Biosciences
$11.60 /

-1.67 (-12.58%)

11/03/20 Piper Sandler
Pacific Biosciences downgraded to Neutral from Overweight at Piper Sandler
10/13/20 Cantor Fitzgerald
Pacific Biosciences price target raised to $17 from $11 at Cantor Fitzgerald
10/02/20
Fly Intel: Top five analyst upgrades
10/02/20 JPMorgan
JPMorgan upgrades Pacific Biosciences to Overweight, triples target to $15
SEDG SolarEdge
$204.20 /

-64.18 (-23.91%)

11/03/20 JPMorgan
SolarEdge weakness should be bought by long-term investors, says JPMorgan
11/03/20 Northland
SolarEdge downgraded to Underperform on valuation, slower recovery at Northland
11/03/20 Roth Capital
SolarEdge price target lowered to $280 from $300 at Roth Capital
11/03/20 Northland
SolarEdge downgraded to Underperform from Market Perform at Northland
HES Hess Corp.
$38.50 /

+0.485 (+1.28%)

11/03/20 Argus
Hess Corp. downgraded to Hold from Buy at Argus
10/16/20 Citi
Hess Midstream Partners upgraded to Buy from Neutral at Citi
10/05/20 UBS
Hess Midstream Partners initiated with a Buy at UBS
09/24/20 Scotiabank
Scotiabank adds EU super majors to coverage, shakes up oil ratings
IPGP IPG Photonics
$190.57 /

+ (+0.00%)

11/03/20 Raymond James
IPG Photonics downgraded to Market Perform from Outperform at Raymond James
11/03/20 Northcoast
IPG Photonics upgraded to Buy from Neutral at Northcoast
11/03/20 Raymond James
IPG Photonics downgraded to Market Perform from Outperform at Raymond James
11/02/20 DA Davidson
IPG Photonics price target raised to $210 from $190 at DA Davidson
NXRT NexPoint Residential
$43.32 /

-1.625 (-3.62%)

11/03/20 Raymond James
NexPoint Residential downgraded to Outperform from Strong Buy at Raymond James
09/15/20 Baird
NexPoint Residential assumed with an Outperform at Baird
08/26/20 Truist
NexPoint Residential price target raised to $44 from $34 at Truist
08/13/20 Raymond James
NexPoint Residential price target raised to $49 from $37 at Raymond James
SEDG SolarEdge
$204.20 /

-64.18 (-23.91%)

PACB Pacific Biosciences
$11.60 /

-1.67 (-12.58%)

NXRT NexPoint Residential
$43.32 /

-1.625 (-3.62%)

IPGP IPG Photonics
$190.57 /

+ (+0.00%)

HES Hess Corp.
$38.50 /

+0.485 (+1.28%)

  • 12
    Aug
PACB Pacific Biosciences
$11.60 /

-1.67 (-12.58%)

HES Hess Corp.
$38.50 /

+0.485 (+1.28%)

SEDG SolarEdge
$204.20 /

-64.18 (-23.91%)

PACB Pacific Biosciences
$11.60 /

-1.67 (-12.58%)

IPGP IPG Photonics
$190.57 /

+ (+0.00%)

HES Hess Corp.
$38.50 /

+0.485 (+1.28%)

SEDG SolarEdge
$204.20 /

-64.18 (-23.91%)

PACB Pacific Biosciences
$11.60 /

-1.67 (-12.58%)

HES Hess Corp.
$38.50 /

+0.485 (+1.28%)

Downgrade
NexPoint Residential downgraded to Outperform from Strong Buy at Raymond James » 09:05
11/03/20
11/03
09:05
11/03/20
09:05
NXRT

NexPoint Residential

$45.00 /

+1.07 (+2.44%)

Raymond James analyst…

Raymond James analyst Buck Horne downgraded NexPoint Residential to Outperform from Strong Buy with a $49 price target. Horne's call is purely a relative valuation adjustment, and the analyst continues to maintain a highly constructive thesis on NexPoint's value-add strategy in high-growth Sun Belt markets.

ShowHide Related Items >><<
NXRT NexPoint Residential
$45.00 /

+1.07 (+2.44%)

NXRT NexPoint Residential
$45.00 /

+1.07 (+2.44%)

09/15/20 Baird
NexPoint Residential assumed with an Outperform at Baird
08/26/20 Truist
NexPoint Residential price target raised to $44 from $34 at Truist
08/13/20 Raymond James
NexPoint Residential price target raised to $49 from $37 at Raymond James
05/18/20 Raymond James
NexPoint Residential upgraded to Strong Buy from Outperform at Raymond James
NXRT NexPoint Residential
$45.00 /

+1.07 (+2.44%)

Hot Stocks
NexPoint Residential raises dividend 9.2% to 34.125c » 07:38
10/27/20
10/27
07:38
10/27/20
07:38
NXRT

NexPoint Residential

$44.38 /

-0.31 (-0.69%)

NexPoint Residential…

NexPoint Residential Trust announced that its board of directors unanimously approved a 9.2% increase in NXRT's quarterly dividend. The board of directors declared a dividend of 34.125 per share of NXRT common stock, payable on December 31 to stockholders of record on December 15.

ShowHide Related Items >><<
NXRT NexPoint Residential
$44.38 /

-0.31 (-0.69%)

NXRT NexPoint Residential
$44.38 /

-0.31 (-0.69%)

09/15/20 Baird
NexPoint Residential assumed with an Outperform at Baird
08/26/20 Truist
NexPoint Residential price target raised to $44 from $34 at Truist
08/13/20 Raymond James
NexPoint Residential price target raised to $49 from $37 at Raymond James
05/18/20 Raymond James
NexPoint Residential upgraded to Strong Buy from Outperform at Raymond James
NXRT NexPoint Residential
$44.38 /

-0.31 (-0.69%)

Hot Stocks
NexPoint Residential reports Q3 NOI up 4.5% » 07:36
10/27/20
10/27
07:36
10/27/20
07:36
NXRT

NexPoint Residential

$44.38 /

-0.31 (-0.69%)

Reports Q3 Same Store…

Reports Q3 Same Store properties average effective rent, total revenue and NOI increased 1.8%, 3.3% and 4.5%, respectively, and occupancy increased 170 bps over the prior year period.

ShowHide Related Items >><<
NXRT NexPoint Residential
$44.38 /

-0.31 (-0.69%)

NXRT NexPoint Residential
$44.38 /

-0.31 (-0.69%)

09/15/20 Baird
NexPoint Residential assumed with an Outperform at Baird
08/26/20 Truist
NexPoint Residential price target raised to $44 from $34 at Truist
08/13/20 Raymond James
NexPoint Residential price target raised to $49 from $37 at Raymond James
05/18/20 Raymond James
NexPoint Residential upgraded to Strong Buy from Outperform at Raymond James
NXRT NexPoint Residential
$44.38 /

-0.31 (-0.69%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.